Kamada Ltd (KMDA)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Kamada Ltd Stock (KMDA) Company Profile

Healthcare (1117)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

KMDA's Discussions on Twitter

Vergleichen Sie KMDA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
KMDA Kamada Ltd	7.98	458.57M	154.57M	15.07M	10.92M	0.27
ZTS Zoetis Inc	126.39	55.90B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.34	51.72B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.915	44.71B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.03	37.30B	16.88B	666.71M	251.19M	0.6132
RGC Regencell Bioscience Holdings Ltd	49.07	20.48B	0	-5.87M	-767.30K	-0.45

Kamada Ltd Stock (KMDA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-21	Eingeleitet	The Benchmark Company	Buy
2024-07-03	Eingeleitet	Stifel	Buy
2018-02-02	Eingeleitet	Chardan Capital Markets	Buy

Kamada Ltd Aktie (KMDA) Neueste Nachrichten

Finanzdaten der Kamada Ltd-Aktie (KMDA)

Kamada Ltd (KMDA)

Kamada Ltd Stock (KMDA) Company Profile

Vergleichen Sie KMDA mit anderen Aktien

Kamada Ltd Stock (KMDA) Upgrades & Downgrades

Kamada Ltd Aktie (KMDA) Neueste Nachrichten

Can Kamada Ltd. stock attract ESG capital inflowsMarket Performance Recap & Low Drawdown Momentum Trade Ideas - ulpravda.ru

Benchmark reiterates Buy rating on Kamada stock, maintains $15 target By Investing.com - Investing.com Nigeria

Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers (NASDAQ:KMDA) - Seeking Alpha

Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus

Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN

Kamada stock rises after issuing 2026 guidance showing double-digit growth - Investing.com Canada

Kamada forecasts 13% revenue growth in 2026, issues guidance By Investing.com - Investing.com Nigeria

Kamada Provides 2026 Annual Guidance of $200$205 Million - GlobeNewswire

Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Kamada Ltd. (KMDA) Stock Analysis: Unearthing an 84% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Leasing LimitedFundamental Strength Indicators & Free Exceptional ROI Methods - bollywoodhelpline.com

Kamada stock rises after issuing 2026 guidance showing double-digit growth By Investing.com - Investing.com South Africa

Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World

Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN

Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga

Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com

Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда

Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда

Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда

Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber

Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks

Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда

Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда

Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria

Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com

Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com

Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks

Kamada secures $10-14 million Canadian supply tender extension - Investing.com

Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire

Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN

Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN

Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn

Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily

Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World

FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World

What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat

Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World

HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World

Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks

Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa

Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga

Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com

Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks

Finanzdaten der Kamada Ltd-Aktie (KMDA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie KMDA